Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
Schroder, 2014, Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up, Lancet, 384, 2027, 10.1016/S0140-6736(14)60525-0
Hugosson, 2010, Mortality results from the Goteborg randomised population-based prostate-cancer screening trial, Lancet Oncol, 11, 725, 10.1016/S1470-2045(10)70146-7
Thompson, 2005, Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower, JAMA, 294, 66, 10.1001/jama.294.1.66
Bak, 2003, Characterisation of prostate cancer missed by sextant biopsy, Clin Prostate Cancer, 2, 115, 10.3816/CGC.2003.n.019
Holmstrom, 2009, Prostate specific antigen for early detection of prostate cancer: longitudinal study, BMJ, 339, b3537, 10.1136/bmj.b3537
Thompson, 2004, Prevalence of prostate cancer among men with a prostate-specific antigen level < or=4.0 ng per milliliter, N Engl J Med, 350, 2239, 10.1056/NEJMoa031918
Kvale, 2009, Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study, BJU Int, 103, 1647, 10.1111/j.1464-410X.2008.08255.x
Epstein, 2012, Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades, Eur Urol, 61, 1019, 10.1016/j.eururo.2012.01.050
Noguchi, 2001, Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer, J Urol, 166, 104, 10.1016/S0022-5347(05)66086-7
Ouzzane, 2011, Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading, Urology, 78, 1356, 10.1016/j.urology.2011.06.022
Sakr, 1994, High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases, In Vivo, 8, 439
Zlotta, 2013, Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men, J Natl Cancer Inst, 105, 1050, 10.1093/jnci/djt151
Soos, 2005, The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study, Eur Urol, 48, 739, 10.1016/j.eururo.2005.08.010
Godtman, 2013, Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Goteborg randomised population-based prostate cancer screening trial, Eur Urol, 63, 101, 10.1016/j.eururo.2012.08.066
Epstein, 1994, Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer, JAMA, 271, 368, 10.1001/jama.1994.03510290050036
Hambrock, 2012, Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort, Eur Urol, 61, 177, 10.1016/j.eururo.2011.08.042
Sciarra, 2011, Advances in magnetic resonance imaging: how they are changing the management of prostate cancer, Eur Urol, 59, 962, 10.1016/j.eururo.2011.02.034
Kuru, 2013, Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate, BJU Int, 112, 1080, 10.1111/bju.12259
Kayat Bittencourt, 2015, Prostate cancer: The European Society of Urogenital Radiology Prostate Imaging Reporting and Data System Criteria for predicting extraprostatic extension by using 3-T multiparametric MR imaging, Radiology, 276, 479, 10.1148/radiol.15141412
Roethke, 2014, Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla, Eur Radiol, 24, 344, 10.1007/s00330-013-3017-5
Kryvenko, 2014, Biopsy criteria for determining appropriateness for active surveillance in the modern era, Urology, 83, 869, 10.1016/j.urology.2013.12.054
Christian Stock TH. DTComPair: comparison of binary diagnostic tests in a paired study design. R package version 1.0.3. R package version 1.0.3. ed2014.
2013
Moskowitz, 2006, Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs, Clin Trials, 3, 272, 10.1191/1740774506cn147oa
World Health Organisation Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. Geneva; 2013.
Tebeu, 2015, Effectiveness of a two-stage strategy with HPV testing followed by visual inspection with acetic acid for cervical cancer screening in a low-income setting, International journal of cancer Journal international du cancer. Int J Cancer, 136, E743, 10.1002/ijc.29250
Haffner, 2011, Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection, BJU Int, 108, E171, 10.1111/j.1464-410X.2011.10112.x
Puech, 2013, Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicentre study, Radiology, 268, 461, 10.1148/radiol.13121501
Randazzo, 2015, A “PSA Pyramid” for Men with initial prostate-specific antigen ≤ 3 ng/ml: A plea for individualised prostate cancer screening, Eur Urol, 68, 591, 10.1016/j.eururo.2014.04.005
Vickers, 2013, Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study, BMJ, 346, f2023, 10.1136/bmj.f2023
Hugosson, 2000, Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden, BJU Int, 85, 1078, 10.1046/j.1464-410x.2000.00679.x
de Rooij, 2014, Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective, Eur Urol, 66, 430, 10.1016/j.eururo.2013.12.012
El-Shater Bosaily, 2015, PROMIS–Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer, Contemp Clin Trials, 42, 26, 10.1016/j.cct.2015.02.008
Baco, 2015, A randomised controlled trial to assess and compare the outcomes of two-core prostate biopsy guided by fused magnetic resonance and transrectal ultrasound images and traditional 12-core systematic biopsy, Eur Urol, 69, 149, 10.1016/j.eururo.2015.03.041
Godtman, 2015
Schroder, 2012, Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomised Study of Screening for Prostate Cancer (ERSPC), Eur Urol, 62, 745, 10.1016/j.eururo.2012.05.068